| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 20, 2020
LAVAL, QC and CAMBRIDGE, UK – March 20, 2020 – Liminal BioSciences Inc. (Nasdaq & TSX: LMNL) (“Liminal BioSciences” or the “Company”), a clinical-stage biopharmaceutical company...
-
Feb 12, 2020
Fibrosis and tissue repair Obesity and non-alcoholic fatty liver disease LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK – February 12, 2020 – Liminal BioSciences Inc. (NASDAQ & TSX:LMNL)...
-
Feb 6, 2020
LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK – February 6, 2020 – Liminal BioSciences Inc. (NASDAQ & TSX: LMNL) (“Liminal BioSciences” or the “Company”), a clinical-stage...
-
Jan 13, 2020
LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK – January 13, 2020 – Liminal BioSciences Inc. (NASDAQ & TSX: LMNL) (“Liminal BioSciences” or the “Company” ), a clinical-stage...
-
Dec 23, 2019
LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK – December 23, 2019 – Liminal BioSciences Inc. (NASDAQ & TSX:LMNL) ( “Liminal BioSciences” or the “Company”), is issuing this news release in...
-
Nov 28, 2019
LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK – November 28, 2019 – Liminal BioSciences Inc. (NASDAQ & TSX:LMNL) ( “Liminal BioSciences” or the “Company” ), a clinical-stage...
-
Nov 27, 2019
LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK – November 27, 2019 – Liminal BioSciences Inc. (NASDAQ & TSX: LMNL) (“Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical...
-
Nov 25, 2019
LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK – November 25, 2019 – Liminal BioSciences Inc. (NASDAQ & TSX: LMNL) (“Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical...
-
Nov 19, 2019
LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK – November 18, 2019 - Liminal BioSciences Inc. (NASDAQ: LMNL, TSX: LMNL) (“Liminal BioSciences” or the “Company”), a clinical-stage...
-
Nov 18, 2019
LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK – November 18, 2019 – Liminal BioSciences Inc. (NASDAQ: LMNL, TSX: LMNL) (“Liminal BioSciences" or the "Company"), a clinical-stage biotechnology...